Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

(18) (27)

Other 95 -

Cash provided by financing activities 1,818 891

Effect of exchange rate changes on cash

and cash equivalents 59 20

Net increase in cash and cash equivalents 616 11

Cash and cash equivalents, beginning of period 365 354

Cash and cash equivalents, end of period $981 $365

Reconciliation of Non-GAAP Measures

This earnings release contains total segment operating profit, net financial debt and net financial debt less readily marketable inventories, which are "non-GAAP financial measures" as this term is defined in Regulation G of the Securities Exchange Act of 1934. In accordance with Regulation G, Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures.

Total Segment Operating Profit

Total segment operating profit, which is the consolidated segment operating profit of all of Bunge's operating segments, is Bunge's consolidated income from operations before income tax that includes interest income of each segment and an allocated portion of the foreign exchange gains and losses and of interest expense relating to debt financing operating working capital, including readily marketable inventories.

Total segment operating profit is a non-GAAP financial measure and is not intended to replace income from operations before income tax, the most directly comparable GAAP financial measure. Total segment operating profit is a key performance measurement used by Bunge's management to evaluate whether operating activities cover the financing costs of its business. Bunge believes total segment operating profit is a more complete measure of its operating profitability, since it allocates foreign exchange gains and losses and the cost of deb
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced ... offering, the underwriters have exercised in full their over-allotment ... is comprised of one common share and 0.4 of ... a price of US$3.00 per unit. Each whole common ...
(Date:12/2/2009)... Gamida Cell announced today,a feasibility study evaluating the ... therapy product which combines technology from Weill,Cornell Medical ... potential to,treat inherited anemias such as Cooley,s Anemia. ... developing a series of technologies to expand, ex ...
(Date:12/2/2009)... CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... a global biopharmaceutical company focused on endocrine therapy ... and Drug Administration (FDA) has granted Fast Track ... perifosine (KRX-0401), for the treatment of relapsed/refractory multiple ...
(Date:12/1/2009)... that he has joined Carolina Eyecare Physicians and ... , which was developed by Medical Consulting Group. ... implant, and cataract surgery expert who has been ... vision correction surgery. He is a member ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
... Angel and venture investors have fewer secrets these days, ... advice to early-stage executives during the National SBIR-STTR Conference. ... ties to the University of Wisconsin-Madison , they ... have a sustainable market advantage, and what each round ...
... HR executives were getting used to having a brisk wind behind ... and economic winds reverse - blowing back against them and at ... press and reports issued by various associations, think tanks, and consulting ... the recruiting machine because 'talent' will soon be (if it isn't ...
... - Merge Healthcare (Nasdaq: MRGE), a financially embattled ... million, or 32 cents per share, during the third quarter ... executives resign and faced delisting from the NASDAQ Stock ... net loss for the first nine months of 2006 of ...
Other Biology Technology:Early-stage executives hear from investors 2Early-stage executives hear from investors 3The misguided talent war 2The misguided talent war 3The misguided talent war 4The misguided talent war 5
(Date:12/3/2009)... 30-year record low in Antarctic snowmelt that occurred during ... strong positive phases for two main climate drivers, ENSO ... Annular Mode), according to Dr. Marco Tedesco, Assistant Professor ... of New York. , Professor Tedesco, who ...
(Date:12/2/2009)... and alcohol consumption before head and neck cancer diagnosis ... to published studies. Now, results of a new study ... habits after cancer diagnosis. , "Most cancer survivors are ... In our study, 21 percent continued to smoke even ...
(Date:12/2/2009)... cancer-free status did not prompt people participating in ... to pick up their cigarettes again, researchers wrote ... Biomarkers & Prevention , a journal of the ... contains a special focus on tobacco. , These ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 1STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 2STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 3Soyfoods a Healthy Choice for Men 48575 1Soyfoods a Healthy Choice for Men 48575 2Soyfoods a Healthy Choice for Men 48575 3Soyfoods a Healthy Choice for Men 48575 4The Hidden Story 3A Poetry Inspired by Authors Struggle with Depression Addiction 48573 1The Hidden Story 3A Poetry Inspired by Authors Struggle with Depression Addiction 48573 2
... EMEA spurs IdentiPHI,s company ... expansion, ... solutions and services, announces its,expansion with the opening of an office in ... authentication (access,management) products and solutions., "Opening the office in Europe will ...
... 2007- Antibiotic resistance is a growing human health ... and other pharmaceuticals to be present in surface ... and underlying groundwater. In a recent article in ... researchers at Colorado State University (CSU) describe a ...
... for decades, but surprisingly, little is known about how ... groundbreaking study published November 28 in the advance online ... the first time measured which of the parasite,s genes ... humans, not in cell cultures, unearthing surprising behaviors and ...
Other Biology News:IdentiPHI Opens Paris Office to Boost European Sales and Support 2Manure management reduces levels of antibiotics and antibiotic resistance genes 2Study of malaria parasite in patient blood finds distinct physiological states 2Study of malaria parasite in patient blood finds distinct physiological states 3Study of malaria parasite in patient blood finds distinct physiological states 4
... The IITC Model 20-NW cuff pump is ... blood pressure testing. This cuff pump replaces manual ... indirect blood pressure test systems for mouse and ... available. The IITC Model 20-NW cuff pump has ...
... are specifically depleted of a single complement ... protein, the alternative and classical pathways are ... for the detection and quantitation of hemolytically ... used to assess complement activation in non-human ...
... by luciferase-cDNA transfected cell lines has proven ... development of reporter gene assays in which ... for the transcription of other genes. The ... to advantages such as high sensitivity and ...
... used to reveal two distinct antigens in ... a Zymed polymer double staining detection method ... same human cell or tissue sample with ... using two different primary antibodies from mouse ...
Biology Products: